Search Legislation

Commission Directive 2004/33/ECShow full title

Commission Directive 2004/33/EC of 22 March 2004 implementing Directive 2002/98/EC of the European Parliament and of the Council as regards certain technical requirements for blood and blood components (Text with EEA relevance)

 Help about what version

What Version

  • Latest available (Revised)
  • Original (As adopted by EU)
 Help about advanced features

Advanced Features

More Resources

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Close

This item of legislation originated from the EU

Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).

Status:

EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.

2.4.For autologous donations, the measures marked with an asterisk (*) are recommendations only.U.K.

Component Quality measurements required The required frequency of sampling for all measurements shall be determined using statistical process control Acceptable results for quality measurements
Red cellsVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 45 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, buffy coat removedVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 43 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, leucocyte-depletedVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 40 g per unit
Leucocyte contentLess than 1 × 106 per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, in additive solutionVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 45 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, buffy coat removed, in additive solutionVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 43 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, leucocyte-depleted, in additive solutionVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 40 g per unit
Leucocyte contentLess than 1 × 106 per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Red cells, apheresisVolumeValid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis
Haemoglobin (*)Not less than 40 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Whole bloodVolume

Valid for storage characteristics to maintain product within specifications for haemoglobin and haemolysis

450 ml +/- 50ml

For paediatric autologous whole blood collections — not to exceed 10,5 ml per kg body weight

Haemoglobin (*)Not less than 45 g per unit
HaemolysisLess than 0,8 % of red cell mass at the end of the shelf life
Platelets, apheresisVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions
pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Platelets, apheresis, leucocyte-depletedVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per single donation are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte contentLess than 1 × 106 per unit
pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Platelets, recovered, pooledVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content

Less than 0,2 × 109 per single unit (platelet-rich plasma method)

Less than 0,05 × 109 per single unit (buffy coat method)

pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Platelets, recovered, pooled, leucocyte-depletedVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per pool are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte contentLess than 1 × 106 per pool
pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Platelets, recovered, single unitVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions
Leucocyte content

Less than 0,2 × 109 per single unit (platelet-rich plasma method)

Less than 0,05 × 109 per single unit (buffy coat method)

pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Platelets, recovered, single unit, leucocyte-depletedVolumeValid for storage characteristics to maintain product within specifications for pH
Platelet contentVariations in platelet content per single unit are permitted within limits that comply with validated preparation and preservation conditions
Leukocyte contentLess than 1 × 106 per unit
pH [F1Minimum 6,4 corrected for 22 °C, at the end of the shelf life]
Plasma, fresh-frozenVolumeStated volume +/- 10 %
Factor VIIIc (*)Average (after freezing and thawing): 70 % or more of the value of the freshly collected plasma unit
Total protein (*)Not less than 50 g/l
Residual cellular content (*)

Red cells: less than 6,0 × 109/l

Leucocytes: less than 0, 1 × 109/l

Platelets: less than 50 × 109/l

Plasma, fresh-frozen, cryoprecipitate-depletedVolumeStated volume: +/- 10 %
Residual cellular content (*)

Red cells: less than 6,0 × 109/l

Leucocytes: less than 0,1 × 109/l

Platelets: less than 50 × 109/l

CryoprecipitateFibrinogen content (*)Greater than or equal to 140 mg per unit
Factor VIIIc content (*)Greater than or equal to 70 international units per unit
Granulocytes, apheresisVolumeLess than 500 ml
Granulocyte contentGreater than 1 × 1010 granulocytes per unit

Back to top

Options/Help

Print Options

Close

Legislation is available in different versions:

Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.

Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.

Close

See additional information alongside the content

Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.

Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.

Close

Opening Options

Different options to open legislation in order to view more content on screen at once

Close

More Resources

Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the EU Official Journal
  • lists of changes made by and/or affecting this legislation item
  • all formats of all associated documents
  • correction slips
  • links to related legislation and further information resources
Close

Timeline of Changes

This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.

The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.

For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.

Close

More Resources

Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:

  • the original print PDF of the as adopted version that was used for the print copy
  • correction slips

Click 'View More' or select 'More Resources' tab for additional information including:

  • lists of changes made by and/or affecting this legislation item
  • confers power and blanket amendment details
  • all formats of all associated documents
  • links to related legislation and further information resources